，/PRNewswire/ -- Robbins Geller Rudman &amp; Dowd LLP 律師事務所宣佈，C3.ai 集體訴訟案 – 標題為 Liggett v. C3.ai, Inc.，案號 No. 25-cv-07129 (N.D. Cal.) – 旨在代表購買或獲取 C3.ai, Inc. (NYSE: AI) 證券的投資者，並指控 C3.ai 及其部分高管違反了 1934 年證券交易法。
如果您遭受了重大損失並希望成為 C3.ai 集體訴訟的主訴人，請在此提供您的信息： https://www.rgrdlaw.com/cases-c3-ai-class-action-lawsuit-ai.html
您也可以通過撥打 800/449-4900 或發送電子郵件至 [email protected] 聯繫 Robbins Geller 的律師 J.C. Sanchez 或 Jennifer N. Caringal。C3.ai 集體訴訟的主訴人動議必須在 2025 年 10 月 21 日（星期二）之前提交法院。
案件指控：C3.ai 作為一家企業人工智能（&#34;AI&#34;）應用軟件公司運營。
C3.ai 集體訴訟指控被告製造了虛假的印象，聲稱他們擁有關於 C3.ai 預期收入前景和預期增長的可靠信息，同時也最小化了因被告首席執行官 Thomas M. Siebel 的健康問題對 C3.ai 盈利能力的風險。根據投訴，C3.ai 對增長、盈利潛力和預期利潤率的樂觀報告與現實相去甚遠，因為它們過於依賴於 C3.ai 首席執行官的健康和有效性。
C3.ai 集體訴訟進一步指控，2025 年 8 月 8 日，C3.ai 宣佈了 2026 財年第一季度令人失望的初步財務結果，並下調了 2026 財年的收入指引，歸因於 “與新領導層的重組” 和首席執行官的健康問題。根據投訴，C3.ai 股票價格因此下跌超過 25%。
主訴人程序：1995 年《私人證券訴訟改革法》允許在集體訴訟期間購買或獲取 C3.ai 證券的任何投資者申請成為 C3.ai 集體訴訟的主訴人。主訴人通常是尋求的救濟中具有最大財務利益的動議人，同時也是潛在集體的典型和適當代表。主訴人代表所有其他集體成員指導 C3.ai 集體訴訟。主訴人可以選擇其所選擇的律師事務所來進行 C3.ai 集體訴訟。投資者分享任何潛在未來賠償的能力並不依賴於作為 C3.ai 集體訴訟的主訴人。
關於 ROBBINS GELLER：Robbins Geller Rudman &amp; Dowd LLP 是全球領先的代表投資者進行證券欺詐和股東訴訟的律師事務所之一。我們的事務所過去五年中有四年在 ISS 證券集體訴訟服務排名中被評為第一，因其為投資者爭取到最多的金錢賠償。根據 ISS，2024 年我們為證券相關集體訴訟案件為投資者追回了超過 25 億美元，超過了下五家律師事務所的總和。Robbins Geller 在 10 個辦公室擁有 200 名律師，是全球最大的原告律師事務所之一，事務所的律師獲得了歷史上許多最大的證券集體訴訟賠償，包括歷史上最大的賠償——72 億美元——在 In re Enron Corp. Sec. Litig. 案件中。有關更多信息，請訪問以下頁面：
https://www.rgrdlaw.com/services-litigation-securities-fraud.html
過去的結果並不保證未來的結果。
服務可能由我們任何辦公室的律師提供。
聯繫方式：
Robbins Geller Rudman &amp; Dowd LLP
J.C. Sanchez, Jennifer N. Caringal
655 W. Broadway, Suite 1900, San Diego, CA 92101
800-449-4900 [email protected]
來源 Robbins Geller Rudman &amp; Dowd LLP
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTE5Jk5ld3NJdGVtSWQ9TEE3NzQyMSZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MTkxNDA1UFJfTkVXU19VU1BSX19fX19MQTc3NDIx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTE5Jk5ld3NJdGVtSWQ9TEE3NzQyMSZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MTkxNDA1UFJfTkVXU19VU1BSX19fX19MQTc3NDIx"/>

C3.ai, Inc. 的投資者如果遭受重大損失，有機會對該公司及其高管提起集體訴訟，指控其違反 1934 年證券交易法。訴訟聲稱，C3.ai 錯誤地表述了其收入前景，並淡化了與首席執行官托馬斯·M·西貝爾健康狀況相關的風險。在 2025 年 8 月 8 日公佈令人失望的財務結果後，C3.ai 的股價下跌超過 25%。有意擔任首席原告的投資者必須在 2025 年 10 月 21 日前提交動議

, /PRNewswire/ -- The law firm of Robbins Geller Rudman &amp; Dowd LLP announces that the C3.ai class action lawsuit – captioned Liggett v. C3.ai, Inc., No. 25-cv-07129 (N.D. Cal.) – seeks to represent purchasers or acquirers of C3.ai, Inc. (NYSE: AI) securities and charges C3.ai as well as certain of C3.ai's top executives with violations of the Securities Exchange Act of 1934.
<div class="lb-trans">，/PRNewswire/ -- Robbins Geller Rudman &amp; Dowd LLP 律師事務所宣佈，C3.ai 集體訴訟案 – 標題為 Liggett v. C3.ai, Inc.，案號 No. 25-cv-07129 (N.D. Cal.) – 旨在代表購買或獲取 C3.ai, Inc. (NYSE: AI) 證券的投資者，並指控 C3.ai 及其部分高管違反了 1934 年證券交易法。
</div>If you suffered substantial losses and wish to serve as lead plaintiff of the C3.ai class action lawsuit, please provide your information here: https://www.rgrdlaw.com/cases-c3-ai-class-action-lawsuit-ai.html
<div class="lb-trans">如果您遭受了重大損失並希望成為 C3.ai 集體訴訟的主訴人，請在此提供您的信息： https://www.rgrdlaw.com/cases-c3-ai-class-action-lawsuit-ai.html
</div>You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. Lead plaintiff motions for the C3.ai class action lawsuit must be filed with the court no later than Tuesday, October 21, 2025.
<div class="lb-trans">您也可以通過撥打 800/449-4900 或發送電子郵件至 [email protected] 聯繫 Robbins Geller 的律師 J.C. Sanchez 或 Jennifer N. Caringal。C3.ai 集體訴訟的主訴人動議必須在 2025 年 10 月 21 日（星期二）之前提交法院。
</div>CASE ALLEGATIONS: C3.ai operates as an enterprise artificial intelligence (&#34;AI&#34;) application software company.
<div class="lb-trans">案件指控：C3.ai 作為一家企業人工智能（&#34;AI&#34;）應用軟件公司運營。
</div>The C3.ai class action lawsuit alleges that defendants created the false impression that they possessed reliable information pertaining to C3.ai's projected revenue outlook and anticipated growth while also minimizing risk to C3.ai's profitability from defendant CEO Thomas M. Siebel's health concerns. In truth, according to the complaint, C3.ai's optimistic reports of growth, earnings potential, and anticipated margins fell short of reality as they relied far too heavily on the health and effectiveness of C3.ai's CEO.
<div class="lb-trans">C3.ai 集體訴訟指控被告製造了虛假的印象，聲稱他們擁有關於 C3.ai 預期收入前景和預期增長的可靠信息，同時也最小化了因被告首席執行官 Thomas M. Siebel 的健康問題對 C3.ai 盈利能力的風險。根據投訴，C3.ai 對增長、盈利潛力和預期利潤率的樂觀報告與現實相去甚遠，因為它們過於依賴於 C3.ai 首席執行官的健康和有效性。
</div>The C3.ai class action lawsuit further alleges that on August 8, 2025, C3.ai announced disappointing preliminary financial results for the first quarter of fiscal year 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing its poor sales results and lowered guidance on &#34;the reorganization with new leadership&#34; and the health ailments of its CEO. On this news, the price of C3.ai stock fell more than 25%, according to the complaint.
<div class="lb-trans">C3.ai 集體訴訟進一步指控，2025 年 8 月 8 日，C3.ai 宣佈了 2026 財年第一季度令人失望的初步財務結果，並下調了 2026 財年的收入指引，歸因於 “與新領導層的重組” 和首席執行官的健康問題。根據投訴，C3.ai 股票價格因此下跌超過 25%。
</div>THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired C3.ai securities during the Class Period to seek appointment as lead plaintiff in the C3.ai class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the C3.ai class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the C3.ai class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the C3.ai class action lawsuit.
<div class="lb-trans">主訴人程序：1995 年《私人證券訴訟改革法》允許在集體訴訟期間購買或獲取 C3.ai 證券的任何投資者申請成為 C3.ai 集體訴訟的主訴人。主訴人通常是尋求的救濟中具有最大財務利益的動議人，同時也是潛在集體的典型和適當代表。主訴人代表所有其他集體成員指導 C3.ai 集體訴訟。主訴人可以選擇其所選擇的律師事務所來進行 C3.ai 集體訴訟。投資者分享任何潛在未來賠償的能力並不依賴於作為 C3.ai 集體訴訟的主訴人。
</div>ABOUT ROBBINS GELLER: Robbins Geller Rudman &amp; Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
<div class="lb-trans">關於 ROBBINS GELLER：Robbins Geller Rudman &amp; Dowd LLP 是全球領先的代表投資者進行證券欺詐和股東訴訟的律師事務所之一。我們的事務所過去五年中有四年在 ISS 證券集體訴訟服務排名中被評為第一，因其為投資者爭取到最多的金錢賠償。根據 ISS，2024 年我們為證券相關集體訴訟案件為投資者追回了超過 25 億美元，超過了下五家律師事務所的總和。Robbins Geller 在 10 個辦公室擁有 200 名律師，是全球最大的原告律師事務所之一，事務所的律師獲得了歷史上許多最大的證券集體訴訟賠償，包括歷史上最大的賠償——72 億美元——在 In re Enron Corp. Sec. Litig. 案件中。有關更多信息，請訪問以下頁面：
</div>https://www.rgrdlaw.com/services-litigation-securities-fraud.html
<div class="lb-trans">https://www.rgrdlaw.com/services-litigation-securities-fraud.html
</div>Past results do not guarantee future outcomes.
<div class="lb-trans">過去的結果並不保證未來的結果。
</div>Services may be performed by attorneys in any of our offices.
<div class="lb-trans">服務可能由我們任何辦公室的律師提供。
</div>Contact:
<div class="lb-trans">聯繫方式：
</div>Robbins Geller Rudman &amp; Dowd LLP
<div class="lb-trans">Robbins Geller Rudman &amp; Dowd LLP
</div>J.C. Sanchez, Jennifer N. Caringal
<div class="lb-trans">J.C. Sanchez, Jennifer N. Caringal
</div>655 W. Broadway, Suite 1900, San Diego, CA 92101
<div class="lb-trans">655 W. Broadway, Suite 1900, San Diego, CA 92101
</div>800-449-4900 [email protected]
<div class="lb-trans">800-449-4900 [email protected]
</div>SOURCE Robbins Geller Rudman &amp; Dowd LLP
<div class="lb-trans">來源 Robbins Geller Rudman &amp; Dowd LLP
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTE5Jk5ld3NJdGVtSWQ9TEE3NzQyMSZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MTkxNDA1UFJfTkVXU19VU1BSX19fX19MQTc3NDIx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA77421&amp;Transmission_Id=202509191405PR_NEWS_USPR_____LA77421&amp;DateId=20250919"/>

14:05 ET
			
			
				C3.AI INVESTOR DEADLINE: C3.ai, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

- C3.ai 正面臨集體訴訟，指控其及高管違反證券法。  
- 訴訟稱 C3.ai 誤導投資者，未披露 CEO 健康問題對盈利的影響。  
- 2025 年 8 月，C3.ai 發佈財報不佳，股價下跌超過 25%。

C3.AI 投資者截止日期：C3.ai, Inc.的投資者如果遭受重大損失，有機會主導投資者集體訴訟